National Bank of Canada
IDNA icon

National Bank of Canada’s iShares Genomics Immunology and Healthcare ETF IDNA Stock Holding History

National Bank of Canada’s Portfolio IDNA Stock Details IDNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$8.28K Buy
+286
New +$8.3K ﹤0.01% 2380
2022
Q3 		– Sell
-600
Closed -$17K – 2777
2022
Q2 		$17K Sell
600
-825
-58% -$24.6K ﹤0.01% 2122
2022
Q1 		$49K Sell
1,425
-250
-15% -$8.83K ﹤0.01% 1873
2021
Q4 		$73K Buy
+1,675
New +$79.3K ﹤0.01% 1732

Other funds holding IDNA

UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
WBG
Wharton Business Group Malvern, Pennsylvania $2.65B AUM 20.73% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
PGA
Portland Global Advisors Portland, Maine $938M AUM 13.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
CCA
Clearwater Capital Advisors Hoffman Estates, Illinois $1.24B AUM 15.23% 1-Year Est. Return

National Bank of Canada's IDNA Position: Q1 2026 in Review

National Bank of Canada opened a new position in iShares Genomics Immunology and Healthcare ETF (IDNA) in Q1 2026: 286 shares worth $8.28K. The stake represents ﹤0.01% of the portfolio and ranks #2380 among its holdings. This is a return to the name: National Bank of Canada previously reported a position in IDNA as recently as Q2 2022.

National Bank of Canada first reported a position in IDNA in Q4 2021 and has held it in 4 quarters since. The position peaked at $73K in Q4 2021. 60 funds tracked by Wall St. Rank hold IDNA as of Q1 2026.

  • National Bank of Canada held 286 shares of iShares Genomics Immunology and Healthcare ETF worth $8.28K as of Q1 2026.
  • iShares Genomics Immunology and Healthcare ETF was a new National Bank of Canada position in Q1 2026.
  • iShares Genomics Immunology and Healthcare ETF made up ﹤0.01% of National Bank of Canada's portfolio in Q1 2026, its #2380 holding.
  • National Bank of Canada first reported a position in iShares Genomics Immunology and Healthcare ETF in Q4 2021 and has held it in 4 quarters since.
  • National Bank of Canada's iShares Genomics Immunology and Healthcare ETF position peaked at $73K in Q4 2021.
  • 60 funds tracked by Wall St. Rank held iShares Genomics Immunology and Healthcare ETF as of Q1 2026.

Based on National Bank of Canada's 13F filing for Q1 2026, filed 15 May 2026.